Actively Recruiting

Age: 0 - 18Years
All Genders
NCT06575270

Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)

Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-02-13

92

Participants Needed

1

Research Sites

87 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Recent retrospective studies have demonstrated differences between pulse oximeter values (SpO2) and measured arterial oxygen saturation (SaO2) in patients identifying as Black or Hispanic. These retrospective studies have limitations because self-reported race is likely not an accurate metric for level of skin pigmentation and the retrospective nature of these studies may impact the accuracy of simultaneous measures of arterial oxygen saturation and pulse oximeter values. The few prospective studies that have evaluated this issue have utilized color-matching techniques to quantify skin pigmentation, and fewer studies have directly measured skin pigmentation in relation it to pulse oximeter accuracy. The aim of this study is to prospectively measure pulse oximeter accuracy in relation to measured levels of skin pigmentation in the congenital heart disease population.

CONDITIONS

Official Title

Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)

Who Can Participate

Age: 0 - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pediatric patients under 18 years old with congenital heart disease (cyanotic or acyanotic)
  • Scheduled for cardiac surgery under general anesthesia with planned arterial access
Not Eligible

You will not qualify if you...

  • Age over 18 years old
  • Emergency surgery
  • Significant preoperative anemia (hemoglobin less than 8.0 g/dL)
  • Preoperative hemodynamic instability requiring more than 1 vasoactive infusion or mechanical circulatory support
  • Colored nail polish on the site planned for pulse oximeter placement
  • Planned use of intravenous dyes during surgery
  • Patient, parent, or guardian refusal to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mount Sinai Hospital

New York, New York, United States, 10029

Actively Recruiting

Loading map...

Research Team

G

Garrett W. Burnett, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD) | DecenTrialz